(Total Views: 79)
Posted On: 10/02/2020 12:05:45 PM
Post# of 89201
$MEIP News Article - Kyowa Kirin and MEI Pharma Announce First Patient Dosed in Japanese Pivotal Phase 2 Study of Zandelisib in Patients with Indolent B-cell non-Hodgkin's Lymphoma https://marketwirenews.com/news-releases/kyow...21460.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
